France · Delayed Price · Currency is EUR ABIONYX Pharma Company Description
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.
It develops CER-001, a negatively-charged lipoprotein particle that contains human recombinant apoA-I, the natural high-density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimic the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis (NASH).
The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019.
ABIONYX Pharma SA was founded in 2005 and is headquartered in Balma, France.
| Country | France |
| Founded | 2005 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 51 |
| CEO | Cyrille Tupin |
Contact Details
Address: 33 43 Ave Georges Pompidou Bldg D2 Balma, 31130 France | |
| Phone | 33 5 62 24 97 06 |
| Website | abionyx.com |
Stock Details
| Ticker Symbol | ABNX |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0012616852 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Sir Cyrille Tupin CPA | Chief Executive Officer, GM and Director |
| Prof. Christian Chavy MBA | Independent Director |
| Emmanuel De Fougeroux | Administrative and Financial Director |
| Constance Keyserling Peyrottes M.S. | Vice President of Clinical, Regulatory Development and Operations |
| Dr. Robert Andrew Donald Scott M.D. | Chief Medical Officer and Head of Research & Development |
| Laurent Guerci | Chief Digital and Innovation Officer |